These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 6711016
1. The effect of hypolipidaemic agents on peroxisomal beta-oxidation and mixed-function oxidase activities in primary cultures of rat hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and lauric acid hydroxylation. Lake BG, Gray TJ, Pels Rijcken WR, Beamand JA, Gangolli SD. Xenobiotica; 1984 Mar; 14(3):269-76. PubMed ID: 6711016 [Abstract] [Full Text] [Related]
2. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat. Amacher DE, Beck R, Schomaker SJ, Kenny CV. Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043 [Abstract] [Full Text] [Related]
3. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds. Dirven HA, van den Broek PH, Peters JG, Noordhoek J, Jongeneelen FJ. Biochem Pharmacol; 1992 Jun 23; 43(12):2621-9. PubMed ID: 1632818 [Abstract] [Full Text] [Related]
4. Hepatic effects of phthalate esters and related compounds--in vivo and in vitro correlations. Lake BG, Gray TJ, Gangolli SD. Environ Health Perspect; 1986 Aug 23; 67():283-90. PubMed ID: 3757955 [Abstract] [Full Text] [Related]
5. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation. Sharma RK, Lake BG, Makowski R, Bradshaw T, Earnshaw D, Dale JW, Gibson GG. Eur J Biochem; 1989 Sep 01; 184(1):69-78. PubMed ID: 2776771 [Abstract] [Full Text] [Related]
6. Experimental studies on pharmacology, metabolism and toxicology with tiadenol-disulfoxide. Dissociation of lipid lowering effects and the induction of peroxisomal and microsomal drug-metabolizing enzymes. Maffei Facino R, Carini M, Tofanetti O, Casciarri I, Longoni E. Arzneimittelforschung; 1987 Jun 01; 37(6):682-91. PubMed ID: 3663266 [Abstract] [Full Text] [Related]
7. Effect of hypolipidemic drugs gemfibrozil, ciprofibrate, and clofibric acid on peroxisomal beta-oxidation in primary cultures of rainbow trout hepatocytes. Donohue M, Baldwin LA, Leonard DA, Kostecki PT, Calabrese EJ. Ecotoxicol Environ Saf; 1993 Oct 01; 26(2):127-32. PubMed ID: 7504609 [Abstract] [Full Text] [Related]
8. Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices. Lake BG, Charzat C, Tredger JM, Renwick AB, Beamand JA, Price RJ. Xenobiotica; 1996 Mar 01; 26(3):297-306. PubMed ID: 8730921 [Abstract] [Full Text] [Related]
11. Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation. Brandes R, Kaikaus RM, Lysenko N, Ockner RK, Bass NM. Biochim Biophys Acta; 1990 Apr 23; 1034(1):53-61. PubMed ID: 2328261 [Abstract] [Full Text] [Related]
13. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Webb SJ, Xiao GH, Geoghegan TE, Prough RA. Mol Pharmacol; 1996 Feb 23; 49(2):276-87. PubMed ID: 8632760 [Abstract] [Full Text] [Related]
14. Lack of stereoselectivity of the peroxisome proliferation induced by 2-phenylpropionic acid: evidence against a role for lipid disturbance in peroxisome proliferation. Ahmad D, Caldwell J. Chirality; 1994 Feb 23; 6(5):365-71. PubMed ID: 8068495 [Abstract] [Full Text] [Related]
15. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Gibson GG, Orton TC, Tamburini PP. Biochem J; 1982 Apr 01; 203(1):161-8. PubMed ID: 7103935 [Abstract] [Full Text] [Related]
16. Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes. Cornu-Chagnon MC, Dupont H, Edgar A. Fundam Appl Toxicol; 1995 Jun 01; 26(1):63-74. PubMed ID: 7657063 [Abstract] [Full Text] [Related]
17. Effects of the peroxisome proliferator mono(2-ethylhexyl)phthalate in primary hepatocyte cultures derived from rat, guinea pig, rabbit and monkey. Relationship between interspecies differences in biotransformation and peroxisome proliferating potencies. Dirven HA, van den Broek PH, Peeters MC, Peters JG, Mennes WC, Blaauboer BJ, Noordhoek J, Jongeneelen FJ. Biochem Pharmacol; 1993 Jun 22; 45(12):2425-34. PubMed ID: 8328980 [Abstract] [Full Text] [Related]
18. Peroxisome proliferation in primary cultures of rat hepatocytes. Gray TJ, Lake BG, Beamand JA, Foster JR, Gangolli SD. Toxicol Appl Pharmacol; 1983 Jan 22; 67(1):15-25. PubMed ID: 6845354 [Abstract] [Full Text] [Related]
19. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid. Orton TC, Parker GL. Drug Metab Dispos; 1982 Jan 22; 10(2):110-5. PubMed ID: 6124394 [Abstract] [Full Text] [Related]
20. Peroxisomal effects of phthalate esters in primary cultures of rat hepatocytes. Gray TJ, Lake BG, Beamand JA, Foster JR, Gangolli SD. Toxicology; 1983 Sep 22; 28(1-2):167-79. PubMed ID: 6636199 [Abstract] [Full Text] [Related] Page: [Next] [New Search]